Balyasny Asset Management’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Balyasny Asset Management’s Portfolio CMAX Stock Details CMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,487	Closed	-$333K	–	3407
2022 Q1	$333K	Buy	+1,487	New	+$308K	﹤0.01%	1903

Other funds holding CMAX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Balyasny Asset Management's CMAX Position: Q2 2022 in Review

Balyasny Asset Management sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q2 2022, closing a stake of 1,487 shares — an estimated $333K sold.

Balyasny Asset Management first reported a position in CMAX in Q1 2022 and held it in 1 quarter. The position peaked at $333K in Q1 2022. 80 funds tracked by Wall St. Rank hold CMAX as of Q2 2022.

Balyasny Asset Management reported no remaining CareMax, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Balyasny Asset Management sold 1,487 CareMax, Inc. Class A Common Stock shares in Q2 2022, an estimated $333K.
Balyasny Asset Management first reported a position in CareMax, Inc. Class A Common Stock in Q1 2022 and held it in 1 quarter.
Balyasny Asset Management's CareMax, Inc. Class A Common Stock position peaked at $333K in Q1 2022.
80 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q2 2022.

Based on Balyasny Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.